Prelude Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Prelude Capital Management’s Portfolio MLTX Stock Details MLTX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$321K	Buy
2024 Q2	–	Sell
2024 Q1	$208K	Sell
2023 Q4	$664K	Buy
2023 Q3	$365K	Buy
2022 Q1	–	Sell
2021 Q4	$495K	Hold
2021 Q3	$498K	Hold
2021 Q2	$518K	Buy